Sponsor or institution
Clinical trials and research at Zealand Pharma
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Zealand Pharma that are recruiting, at sites in 15 countries (most in Netherlands (3), Poland (2), Germany (2)). By phase: Phase 1 (3), Phase 3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 15Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How safe and well ZP9830 works in people with plaque psoriasis over 8 weeks | Phase 1 | Leiden, South Holland | Recruiting | Jul 29, 2026 |
| ZP6590 safety and dosing in adults with varying weight | Early Phase 1 | Neuss, North Rhine-Westphalia | Recruiting | Jul 23, 2026 |
| Petrelintide pharmacokinetics in people with different levels of liver function | Phase 1 | Wroclaw, Poland and 2 other locations | Recruiting | Jul 6, 2026 |
| Glepaglutide for adults with short bowel syndrome and intestinal failure | Phase 3 | Chicago, Illinois and 32 other locations | Recruiting | Sep 30, 2025 |
| Investigating the safety of ZP9830 in healthy participants | Phase 1 | Leiden, CL | Recruiting | Nov 12, 2024 |
All recruiting trials (5)
-
How safe and well ZP9830 works in people with plaque psoriasis over 8 weeks
This study tests whether ZP9830 is safe and tolerable in adults with plaque psoriasis for 8 weeks, with a comparison to placebo.
-
ZP6590 safety and dosing in adults with varying weight
This study tests ZP6590 in adults with normal weight, overweight, and obesity to see if it is safe and tolerable and to understand how the drug behaves in the body.
-
Petrelintide pharmacokinetics in people with different levels of liver function
This study tests how petrelintide behaves in the body after a single dose in adults with obesity or overweight and varying liver function.
-
Glepaglutide for adults with short bowel syndrome and intestinal failure
This trial tests whether glepaglutide 10 mg given twice weekly can reduce the need for parenteral support in adults with short bowel syndrome and intestinal failure.
-
Investigating the safety of ZP9830 in healthy participants
This study is testing the safety of a new drug called ZP9830 in healthy people to see how it works in the body compared to a placebo.
Quick answers
How many clinical trials run by Zealand Pharma are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in Netherlands (3 trials), Poland (2 trials), Germany (2 trials), Slovakia (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.